8372 Stock Overview
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Grand Brilliance Group Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.10 |
| 52 Week High | HK$0.11 |
| 52 Week Low | HK$0.07 |
| Beta | 0.38 |
| 1 Month Change | 1.00% |
| 3 Month Change | 8.60% |
| 1 Year Change | 32.89% |
| 3 Year Change | 21.69% |
| 5 Year Change | -15.13% |
| Change since IPO | -74.75% |
Recent News & Updates
Estimating The Intrinsic Value Of Grand Brilliance Group Holdings Limited (HKG:8372)
Oct 31
Grand Brilliance Group Holdings (HKG:8372) Will Be Hoping To Turn Its Returns On Capital Around
Sep 21Recent updates
Estimating The Intrinsic Value Of Grand Brilliance Group Holdings Limited (HKG:8372)
Oct 31Grand Brilliance Group Holdings (HKG:8372) Will Be Hoping To Turn Its Returns On Capital Around
Sep 21Grand Brilliance Group Holdings (HKG:8372) Will Want To Turn Around Its Return Trends
Oct 28Estimating The Intrinsic Value Of Grand Brilliance Group Holdings Limited (HKG:8372)
Aug 29A Look At The Fair Value Of Grand Brilliance Group Holdings Limited (HKG:8372)
Apr 29Returns On Capital At Grand Brilliance Group Holdings (HKG:8372) Paint A Concerning Picture
Mar 16Increases to Grand Brilliance Group Holdings Limited's (HKG:8372) CEO Compensation Might Cool off for now
Sep 10Weak Statutory Earnings May Not Tell The Whole Story For Grand Brilliance Group Holdings (HKG:8372)
Jul 02Grand Brilliance Group Holdings (HKG:8372) Could Be Struggling To Allocate Capital
May 11Is Now The Time To Put Grand Brilliance Group Holdings (HKG:8372) On Your Watchlist?
Mar 17We're Watching These Trends At Grand Brilliance Group Holdings (HKG:8372)
Feb 08
Have Grand Brilliance Group Holdings Limited (HKG:8372) Insiders Been Selling Their Stock?
Dec 31Shareholder Returns
| 8372 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 7.4% | -0.5% | 2.2% |
| 1Y | 32.9% | -27.9% | -7.9% |
Return vs Industry: 8372 exceeded the Hong Kong Healthcare industry which returned -27.9% over the past year.
Return vs Market: 8372 exceeded the Hong Kong Market which returned -7.9% over the past year.
Price Volatility
| 8372 volatility | |
|---|---|
| 8372 Average Weekly Movement | 7.0% |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in HK Market | 14.9% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 8372 has not had significant price volatility in the past 3 months.
Volatility Over Time: 8372's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 44 | Bikie Wong | www.grandbrilliancegroup.com |
Grand Brilliance Group Holdings Limited, an investment holding company, engages in supplying of medical devices in Hong Kong. It offers medical consumables; medical instruments; and medical equipment, as well as develops healthcare products. The company also provides medical device solutions, such as market trend analysis, sourcing of medical devices, after-sale services, technical support and training services, medical devices leasing services, and quality assurance services; and maintenance services, as well as holds trademarks.
Grand Brilliance Group Holdings Limited Fundamentals Summary
| 8372 fundamental statistics | |
|---|---|
| Market cap | HK$80.80m |
| Earnings (TTM) | HK$7.86m |
| Revenue (TTM) | HK$84.98m |
10.3x
P/E Ratio1.0x
P/S RatioIs 8372 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8372 income statement (TTM) | |
|---|---|
| Revenue | HK$84.98m |
| Cost of Revenue | HK$42.40m |
| Gross Profit | HK$42.59m |
| Other Expenses | HK$34.73m |
| Earnings | HK$7.86m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0098 |
| Gross Margin | 50.11% |
| Net Profit Margin | 9.25% |
| Debt/Equity Ratio | 0% |
How did 8372 perform over the long term?
See historical performance and comparison